Maiwei Biotech voluntarily discloses an announcement on the progress of clinical research on 9MW2821 for triple negative breast cancer indications (TNBC)

SZSI · May 13

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.